Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Determinants of non-adherence to adjuvant endocrine treatment in women with breast cancer: the role of comorbidity.

Wulaningsih W, Garmo H, Ahlgren J, Holmberg L, Folkvaljon Y, Wigertz A, Van Hemelrijck M, Lambe M.

Breast Cancer Res Treat. 2018 Nov;172(1):167-177. doi: 10.1007/s10549-018-4890-z. Epub 2018 Jul 21.

2.

Socioeconomic factors and penile cancer risk and mortality; a population-based study.

Torbrand C, Wigertz A, Drevin L, Folkvaljon Y, Lambe M, Håkansson U, Kirrander P.

BJU Int. 2017 Feb;119(2):254-260. doi: 10.1111/bju.13534. Epub 2016 Jul 4.

3.

Cohort Profile Update: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base--a refined prostate cancer trajectory.

Van Hemelrijck M, Garmo H, Wigertz A, Nilsson P, Stattin P.

Int J Epidemiol. 2016 Feb;45(1):73-82. doi: 10.1093/ije/dyv305. Epub 2015 Dec 11. No abstract available.

4.

Evaluation of data quality in the National Prostate Cancer Register of Sweden.

Tomic K, Sandin F, Wigertz A, Robinson D, Lambe M, Stattin P.

Eur J Cancer. 2015 Jan;51(1):101-11. doi: 10.1016/j.ejca.2014.10.025. Epub 2014 Nov 20.

PMID:
25465187
5.

Serum glucose and fructosamine in relation to risk of cancer.

Wulaningsih W, Holmberg L, Garmo H, Zethelius B, Wigertz A, Carroll P, Lambe M, Hammar N, Walldius G, Jungner I, Van Hemelrijck M.

PLoS One. 2013;8(1):e54944. doi: 10.1371/journal.pone.0054944. Epub 2013 Jan 25.

6.

Impact of comorbidity on management and mortality in women diagnosed with breast cancer.

Berglund A, Wigertz A, Adolfsson J, Ahlgren J, Fornander T, Wärnberg F, Lambe M.

Breast Cancer Res Treat. 2012 Aug;135(1):281-9. doi: 10.1007/s10549-012-2176-4. Epub 2012 Jul 26.

PMID:
22829398
7.

Lipid profiles and the risk of endometrial cancer in the Swedish AMORIS study.

Seth D, Garmo H, Wigertz A, Holmberg L, Hammar N, Jungner I, Lambe M, Walldius G, Van Hemelrijck M.

Int J Mol Epidemiol Genet. 2012;3(2):122-33. Epub 2012 May 15.

8.

Lipid profiles and risk of breast and ovarian cancer in the Swedish AMORIS study.

Melvin JC, Seth D, Holmberg L, Garmo H, Hammar N, Jungner I, Walldius G, Lambe M, Wigertz A, Van Hemelrijck M.

Cancer Epidemiol Biomarkers Prev. 2012 Aug;21(8):1381-4. doi: 10.1158/1055-9965.EPI-12-0188. Epub 2012 May 16.

9.

Cohort Profile: the National Prostate Cancer Register of Sweden and Prostate Cancer data Base Sweden 2.0.

Van Hemelrijck M, Wigertz A, Sandin F, Garmo H, Hellström K, Fransson P, Widmark A, Lambe M, Adolfsson J, Varenhorst E, Johansson JE, Stattin P; NPCR and PCBaSe Sweden.

Int J Epidemiol. 2013 Aug;42(4):956-67. doi: 10.1093/ije/dys068. Epub 2012 May 4.

PMID:
22561842
10.

Adherence and discontinuation of adjuvant hormonal therapy in breast cancer patients: a population-based study.

Wigertz A, Ahlgren J, Holmqvist M, Fornander T, Adolfsson J, Lindman H, Bergkvist L, Lambe M.

Breast Cancer Res Treat. 2012 May;133(1):367-73. doi: 10.1007/s10549-012-1961-4.

PMID:
22286315
11.

Pancreatic cancer; reporting and long-term survival in Sweden.

Lambe M, Eloranta S, Wigertz A, Blomqvist P.

Acta Oncol. 2011 Nov;50(8):1220-7. doi: 10.3109/0284186X.2011.599338. Epub 2011 Aug 3.

PMID:
21812626
12.

Impaired glucose metabolism and diabetes and the risk of breast, endometrial, and ovarian cancer.

Lambe M, Wigertz A, Garmo H, Walldius G, Jungner I, Hammar N.

Cancer Causes Control. 2011 Aug;22(8):1163-71. doi: 10.1007/s10552-011-9794-8. Epub 2011 Jun 19.

PMID:
21688131
13.

Breast cancer, sickness absence, income and marital status. A study on life situation 1 year prior diagnosis compared to 3 and 5 years after diagnosis.

Eaker S, Wigertz A, Lambert PC, Bergkvist L, Ahlgren J, Lambe M; Uppsala/Örebro Breast Cancer Group.

PLoS One. 2011 Mar 30;6(3):e18040. doi: 10.1371/journal.pone.0018040.

14.

Non-participant characteristics and the association between socioeconomic factors and brain tumour risk.

Wigertz A, Lönn S, Hall P, Feychting M.

J Epidemiol Community Health. 2010 Aug;64(8):736-43. doi: 10.1136/jech.2008.085845.

PMID:
20670977
15.

Interaction between 5 genetic variants and allergy in glioma risk.

Schoemaker MJ, Robertson L, Wigertz A, Jones ME, Hosking FJ, Feychting M, Lönn S, McKinney PA, Hepworth SJ, Muir KR, Auvinen A, Salminen T, Kiuru A, Johansen C, Houlston RS, Swerdlow AJ.

Am J Epidemiol. 2010 Jun 1;171(11):1165-73. doi: 10.1093/aje/kwq075. Epub 2010 May 12.

PMID:
20462933
16.

Reductions in use of hormone replacement therapy: effects on Swedish breast cancer incidence trends only seen after several years.

Lambe M, Wigertz A, Holmqvist M, Adolfsson J, Bardage C, Fornander T, Karlsson P, Odlind V, Persson I, Ahlgren J, Bergkvist L.

Breast Cancer Res Treat. 2010 Jun;121(3):679-83. doi: 10.1007/s10549-009-0615-7. Epub 2009 Nov 6.

PMID:
19894110
17.

Reproductive factors and risk of meningioma and glioma.

Wigertz A, Lönn S, Hall P, Auvinen A, Christensen HC, Johansen C, Klaeboe L, Salminen T, Schoemaker MJ, Swerdlow AJ, Tynes T, Feychting M.

Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2663-70. doi: 10.1158/1055-9965.EPI-08-0406.

18.

An international case-control study of interleukin-4Ralpha, interleukin-13, and cyclooxygenase-2 polymorphisms and glioblastoma risk.

Schwartzbaum JA, Ahlbom A, Lönn S, Malmer B, Wigertz A, Auvinen A, Brookes AJ, Collatz Christensen H, Henriksson R, Johansen C, Salminen T, Schoemaker MJ, Swerdlow AJ, Debinski W, Feychting M.

Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2448-54.

19.

Allergic conditions and brain tumor risk.

Wigertz A, Lönn S, Schwartzbaum J, Hall P, Auvinen A, Christensen HC, Johansen C, Klaeboe L, Salminen T, Schoemaker MJ, Swerdlow AJ, Tynes T, Feychting M.

Am J Epidemiol. 2007 Oct 15;166(8):941-50. Epub 2007 Jul 23.

PMID:
17646205
20.

Risk of brain tumors associated with exposure to exogenous female sex hormones.

Wigertz A, Lönn S, Mathiesen T, Ahlbom A, Hall P, Feychting M; Swedish Interphone Study Group.

Am J Epidemiol. 2006 Oct 1;164(7):629-36. Epub 2006 Jul 11.

PMID:
16835295
21.

Measures of prevalence: which healthcare registers are applicable?

Wigertz A, Westerling R.

Scand J Public Health. 2001 Mar;29(1):55-62.

PMID:
11355718
22.

No negative influence of EMLA application prior to BCG vaccination.

Dohlwitz A, Hellenberg L, Svedmyr J, Tober L, Wigertz A.

Acta Paediatr. 1998 Apr;87(4):480-1. No abstract available.

PMID:
9628315
23.

Comparison between one and three years of treatment in uncomplicated childhood epilepsy: a prospective study. I. Outcome in different seizure types.

Braathen G, Andersson T, Gylje H, Melander H, Naglo AS, Norén L, Persson A, Rane A, Sjörs K, Theorell K, Wigertz A.

Epilepsia. 1996 Sep;37(9):822-32.

PMID:
8814094
24.

Immunoglobulin abnormalities in cerebrospinal fluid and blood in children with febrile seizures.

Eeg-Olofsson O, Wigertz A, Link H.

Neuropediatrics. 1982 Feb;13(1):39-41.

PMID:
7078707
25.

HLA and epilepsy: an investigation of different types of epilepsy in children and their families.

Eeg-Olofsson O, Säfwenberg J, Wigertz A.

Epilepsia. 1982 Feb;23(1):27-34. No abstract available.

PMID:
6948684
27.

Apparently non-deleted ring-1 chromosome and extreme growth failure in a mentally retarded girl.

Kjessler B, Gustavson KH, Wigertz A.

Clin Genet. 1978 Jul;14(1):8-15.

PMID:
679524

Supplemental Content

Loading ...
Support Center